John T. Vetto
- Oncology top 0.5%
- Cutaneous Melanoma Detection and Management 58
- CAR-T cell therapy research 23
- Immunology top 0.5%
- Immunotherapy and Immune Responses 18
- Cancer Research top 5%
- Breast Cancer Treatment Studies 18
- Cancer Genomics and Diagnostics 11
- Dermatology top 1%
-
- Breast Lesions and Carcinomas 17
-
- Nonmelanoma Skin Cancer Studies 23
-
- Melanoma and MAPK Pathways 21
- Co-authors
- Steven A. RosenbergMichael T. LotzeAlfred E. ChangStephen E. EttinghausenClaudia A. SeippYvedt L. MatoryEitan ShiloniLinda Muul
- Cited by
- OncologyImmunologyCancer Research
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (14 papers)The Journal of Immunology (1 paper)
- Partner nations
- United StatesIsraelJapan
In The Last Decade
John T. Vetto
158 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 3.8k
- Immunology 2.8k
- Cancer Research 599
- Dermatology 345
- Pathology and Forensic Medicine 547
Countries citing papers authored by John T. Vetto
This map shows the geographic impact of John T. Vetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Vetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Vetto more than expected).
Fields of papers citing papers by John T. Vetto
This network shows the impact of papers produced by John T. Vetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Vetto. The network helps show where John T. Vetto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John T. Vetto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 16 | |
| 6 | 2020 | 6 | |
| 7 | 2019 | 12 | |
| 8 | 2019 | 8 | |
| 9 | 2017 | 21 | |
| 10 | 2017 | 4 | |
| 11 | 2016 | 10 | |
| 12 | 2015 | 104 | |
| 13 | 2013 | 161 | |
| 14 | 2010 | 39 | |
| 15 | 2009 | 10 | |
| 16 | 2009 | 6 | |
| 17 | 2008 | 23 | |
| 18 | 2003 | 9 | |
| 19 | 2000 | 315 | |
| 20 | 1989 | 25 |
About John T. Vetto
John T. Vetto is a scholar working on Oncology, Cancer Research and Microbiology, having authored 164 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (58 papers), CAR-T cell therapy research (23 papers), Nonmelanoma Skin Cancer Studies (23 papers), Melanoma and MAPK Pathways (21 papers), Breast Cancer Treatment Studies (18 papers), Immunotherapy and Immune Responses (18 papers), Breast Lesions and Carcinomas (17 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Oncology (3.8k citations), Immunology (2.8k citations) and Cancer Research (599 citations). John T. Vetto has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Steven A. Rosenberg, Michael T. Lotze, Alfred E. Chang, Stephen E. Ettinghausen, Claudia A. Seipp, Yvedt L. Matory, Eitan Shiloni, Linda Muul, Susan F. Leitman and Colleen Simpson. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.